RITUXIMAB-ARRX

0 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking RITUXIMAB-ARRX:

# Side effect Count
See all common reactions for RITUXIMAB-ARRX

RITUXIMAB-ARRX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
See all enriched reactions for RITUXIMAB-ARRX